EC Number |
Inhibitors |
Structure |
---|
4.1.3.30 | (4E)-4-[(4,7-dichloro-2-phenyl-1H-indol-3-yl)methylidene]-2,4-dihydro-3H-pyrazol-3-one |
- |
|
4.1.3.30 | (4E)-4-[(5-methyl-2-phenyl-1H-indol-3-yl)methylidene]-2,4-dihydro-3H-pyrazol-3-one |
- |
|
4.1.3.30 | (4E)-4-[(6,7-dichloro-2-phenyl-1H-indol-3-yl)methylidene]-2,4-dihydro-3H-pyrazol-3-one |
- |
|
4.1.3.30 | (4Z)-5-methyl-4-[(1H-pyrrol-2-yl)methylidene]-2,4-dihydro-3H-pyrazol-3-one |
- |
|
4.1.3.30 | (4Z)-5-methyl-4-[(pyridin-4-yl)methylidene]-2,4-dihydro-3H-pyrazol-3-one |
- |
|
4.1.3.30 | 3-(4,7-dichloro-2-phenyl-1H-indol-3-yl)-4-methyl-3a,6-dihydropyrazolo[3,4-c]pyrazole-2(3H)-carbothioamide |
- |
|
4.1.3.30 | 3-(6,7-dichloro-2-phenyl-1H-indol-3-yl)-4-methyl-3a,6-dihydropyrazolo[3,4-c]pyrazole-2(3H)-carbothioamide |
- |
|
4.1.3.30 | 3-(6,7-dichloro-2-phenyl-1H-indol-3-yl)-4-methyl-3a,6-dihydropyrazolo[3,4-c]pyrazole-2(3H)-carboxamide |
- |
|
4.1.3.30 | 3-Bromopyruvate |
complete inactivation at equimolar concentrations |
|
4.1.3.30 | 4-methyl-3-(1H-pyrrol-2-yl)-3a,6-dihydropyrazolo[3,4-c]pyrazole-2(3H)-carboxamide |
- |
|